Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding.
Chondroitin sulfate (CS) is abundantly present in the tumor stroma, and tumor-specific CS modifications might be potential targets to influence tumor development. We applied the phage display technology to select antibodies that identify these tumor-specific CS modifications. Antibody GD3G7 was selected against embryonic glycosaminoglycans, and it reacted strongly with CS-E (rich in GlcA-GalNAc4S6S units). In ovarian adenocarcinomas, strong expression of this CS-E epitope was found in the extracellular matrix, and occasionally on tumor cells. No expression was found in normal ovary and cystadenomas. Differential expression was found in ovarian carcinoma cell lines, which correlated with the gene expression of the GalNAc4S-6st enzyme, involved in biosynthesis of CS-E. Vascular endothelial growth factor (VEGF)-sensitive fenestrated (in normal tissues) and tumor blood vessels were both identified by antibody GD3G7, which might implicate a role for CS-E in VEGF biology. VEGF bound to CS-E and antibody GD3G7 could compete for binding of VEGF to CS-E. In conclusion, antibody GD3G7 identified rare CS-E-like structures that were strongly expressed in ovarian adenocarcinomas. This antibody might therefore be instrumental for identifying tumor-related CS alterations.
ten Dam
Gerdy B
GB
Department of Biochemistry 280, Nijmegen Center for Molecular Life Sciences, Radboud University Nijmegen Medical Center, PO. Box 9101, 6500 HB Nijmegen, The Netherlands. g.tendam@ncmls.ru.nl
van de Westerlo
Els M A
EM
Purushothaman
Anurag
A
Stan
Radu V
RV
Bulten
Johan
J
Sweep
Fred C G J
FC
Massuger
Leon F
LF
Sugahara
Kazuyuki
K
van Kuppevelt
Toin H
TH
D000230:Adenocarcinoma / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D000912:Antibodies, Neoplasm / Q000276:immunology*; D045744:Cell Line, Tumor; D002809:Chondroitin Sulfates / Q000032:analysis* / Q000276:immunology / Q000378:metabolism*; D000939:Epitopes / Q000032:analysis / Q000276:immunology / Q000378:metabolism; D005260:Female; D015870:Gene Expression; D006025:Glycosaminoglycans / Q000276:immunology; D006801:Humans; D008562:Membrane Glycoproteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D051379:Mice; D010051:Ovarian Neoplasms / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D019151:Peptide Library; D051381:Rats; D015238:Sulfotransferases / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D015854:Up-Regulation; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors / Q000378:metabolism*
D000912:Antibodies, Neoplasm; C411874:CHST15 protein, human; D000939:Epitopes; D006025:Glycosaminoglycans; D008562:Membrane Glycoproteins; D019151:Peptide Library; D042461:Vascular Endothelial Growth Factor A; C524376:antibody GD3G7, human; D002809:Chondroitin Sulfates; D015238:Sulfotransferases
Trends Pharmacol Sci. 2001 Apr;22(4):201-7
11282421
Eur J Pharmacol. 2001 Mar 30;416(3):213-21
11290371
Biochemistry. 2001 Oct 23;40(42):12654-65
11601990
Pathol Oncol Res. 2001;7(4):260-6
11882905
J Biol Chem. 2002 Mar 29;277(13):10982-6
11790764
J Biol Chem. 2002 Apr 12;277(15):12921-30
11821431
Clin Cancer Res. 2002 Jun;8(6):1754-60
12060613
Biochim Biophys Acta. 2002 Nov 20;1588(2):165-72
12385781
J Biol Chem. 2002 Nov 15;277(46):43707-16
12221095
Int J Biochem Cell Biol. 2003 Mar;35(3):376-90
12531251
J Histochem Cytochem. 2003 Jun;51(6):727-39
12754284
Cancer Res. 2003 Jun 1;63(11):2965-70
12782604
Int J Cancer. 2003 Nov 10;107(3):359-64
14506734
Curr Opin Struct Biol. 2003 Oct;13(5):605-11
14568616
Curr Opin Struct Biol. 2003 Oct;13(5):612-20
14568617
J Biol Chem. 2003 Oct 31;278(44):43744-54
12917413
J Invest Dermatol. 2004 Mar;122(3):707-16
15086557
J Biol Chem. 2004 Sep 10;279(37):38346-52
15247295
J Pathol. 1991 Oct;165(2):145-52
1720817
Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13203-7
10557298
Glycoconj J. 1999 Jun;16(6):291-305
10579698
J Neurosci. 2000 Jun 1;20(11):4099-111
10818145
Biochim Biophys Acta. 2000 Oct 18;1502(2):201-6
11040445
EMBO J. 1994 Feb 1;13(3):692-8
7508862
Anal Biochem. 1994 Sep;221(2):356-61
7529008
J Biol Chem. 1997 Aug 8;272(32):19656-65
9242620
J Biol Chem. 1998 Jan 2;273(1):51-7
9417046
Eur J Biochem. 1998 Mar 15;252(3):576-82
9546676
J Biol Chem. 1998 May 22;273(21):12960-6
9582329
Eur J Biochem. 1998 Jun 1;254(2):371-7
9660193
J Cell Biol. 1999 Jun 14;145(6):1189-98
10366592
J Biol Chem. 2004 Dec 3;279(49):50799-809
15385557
J Biol Chem. 2005 Feb 11;280(6):4058-69
15557276
Glycobiology. 2005 Jun;15(6):593-603
15625183
J Biol Chem. 2005 Jun 17;280(24):23184-93
15849184
Physiol Rev. 2005 Jul;85(3):979-1000
15987800
Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H560-76
16172168
J Biol Chem. 2006 Jan 20;281(3):1731-40
16258170
J Biol Chem. 2006 Feb 24;281(8):4654-62
16373349
Nat Rev Mol Cell Biol. 2006 May;7(5):359-71
16633338
Am J Physiol Renal Physiol. 2006 Jun;290(6):F1355-66
16380456
EMBO J. 2006 Jul 12;25(13):3045-55
16763549
J Biochem. 2006 Oct;140(4):517-24
16936295
Biomaterials. 2007 Feb;28(6):1123-31
17113636
Adv Pharmacol. 2006;53:253-79
17239770
J Biol Chem. 2007 Jul 6;282(27):19442-52
17500059